These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 32397365)

  • 1. Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure.
    Nielsen MC; Hvidbjerg Gantzel R; Clària J; Trebicka J; Møller HJ; Grønbæk H
    Cells; 2020 May; 9(5):. PubMed ID: 32397365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease.
    Nielsen MC; Andersen MN; Grønbæk H; Damgaard Sandahl T; Møller HJ
    Scand J Gastroenterol; 2020 May; 55(5):588-596. PubMed ID: 32393080
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).
    Grønbæk H; Rødgaard-Hansen S; Aagaard NK; Arroyo V; Moestrup SK; Garcia E; Solà E; Domenicali M; Piano S; Vilstrup H; Møller HJ;
    J Hepatol; 2016 Apr; 64(4):813-22. PubMed ID: 26639396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms.
    Nielsen MC; Andersen MN; Rittig N; Rødgaard-Hansen S; Grønbaek H; Moestrup SK; Møller HJ; Etzerodt A
    J Leukoc Biol; 2019 Nov; 106(5):1129-1138. PubMed ID: 31242338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum macrophage-mannose receptor CD206 with mortality in idiopathic pulmonary fibrosis.
    Zou R; Gui X; Zhang J; Tian Y; Liu X; Tian M; Chen T; Wu H; Chen J; Dai J; Cai H
    Int Immunopharmacol; 2020 Sep; 86():106732. PubMed ID: 32622200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
    Grønbaek H; Møller HJ; Saliba F; Zeuzem S; Albillos A; Ariza X; Graupera I; Solà E; Amoros A; Pavesi M; Bossen L; Jalan R; Gines P; Arroyo V
    J Gastroenterol Hepatol; 2021 Jan; 36(1):240-248. PubMed ID: 32478437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis.
    Heftdal LD; Loft AG; Hendricks O; Ashouri Christiansen A; Schiøttz-Christensen B; Arnbak B; Jurik AG; Østgård R; Winding Deleuran B; Møller HJ; Greisen SR
    Scand J Clin Lab Invest; 2018 Oct; 78(6):483-489. PubMed ID: 30176763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
    Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H
    J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients.
    Kjærgaard AG; Rødgaard-Hansen S; Dige A; Krog J; Møller HJ; Tønnesen E
    PLoS One; 2014; 9(3):e92331. PubMed ID: 24637679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.
    Andersen ES; Rødgaard-Hansen S; Moessner B; Christensen PB; Møller HJ; Weis N
    Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):117-22. PubMed ID: 24424890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic potential of the macrophage specific receptor CD163 in inflammatory diseases.
    Buechler C; Eisinger K; Krautbauer S
    Inflamm Allergy Drug Targets; 2013 Dec; 12(6):391-402. PubMed ID: 24090317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation markers are associated with infection and mortality in patients with acute liver failure.
    Cavazza A; Triantafyllou E; Savoldelli R; Mujib S; Jerome E; Trovato FM; Artru F; Sheth R; Huang XH; Ma Y; Dazzi F; Pirani T; Antoniades CG; Lee WM; McPhail MJ; Karvellas CJ;
    Liver Int; 2024 Aug; 44(8):1900-1911. PubMed ID: 38588014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma.
    Andersen MN; Andersen NF; Rødgaard-Hansen S; Hokland M; Abildgaard N; Møller HJ
    Leuk Res; 2015 Sep; 39(9):971-5. PubMed ID: 26169445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
    Lidofsky A; Holmes JA; Feeney ER; Kruger AJ; Salloum S; Zheng H; Seguin IS; Altinbas A; Masia R; Corey KE; Gustafson JL; Schaefer EA; Hunt PW; Deeks S; Somsouk M; Chew KW; Chung RT; Alatrakchi N
    J Infect Dis; 2018 Sep; 218(9):1394-1403. PubMed ID: 29868909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.
    Horiike Y; Suzuki Y; Fujisawa T; Yasui H; Karayama M; Hozumi H; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Ogawa N; Suda T
    Rheumatology (Oxford); 2019 Dec; 58(12):2143-2152. PubMed ID: 31143953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Macrophage Mannose Receptor (sCD206/sMR) as a Biomarker in Human Immunodeficiency Virus Infection.
    Andersen MN; Hønge BL; Jespersen S; Medina C; da Silva Té D; Laursen A; Wejse C; Erikstrup C; Møller HJ;
    J Infect Dis; 2018 Sep; 218(8):1291-1295. PubMed ID: 29800140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subpopulation of CD163-positive macrophages is classically activated in psoriasis.
    Fuentes-Duculan J; Suárez-Fariñas M; Zaba LC; Nograles KE; Pierson KC; Mitsui H; Pensabene CA; Kzhyshkowska J; Krueger JG; Lowes MA
    J Invest Dermatol; 2010 Oct; 130(10):2412-22. PubMed ID: 20555352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CD163, CD204 and CD206 on alveolar macrophages in the lungs of patients with severe chronic obstructive pulmonary disease.
    Kaku Y; Imaoka H; Morimatsu Y; Komohara Y; Ohnishi K; Oda H; Takenaka S; Matsuoka M; Kawayama T; Takeya M; Hoshino T
    PLoS One; 2014; 9(1):e87400. PubMed ID: 24498098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of CD163+ Macrophages and CD206+ Cells in Lesional Skin of CD30+ Lymphoproliferative Disorders of Lymphomatoid Papulosis and Primary Cutaneous Anaplastic Large-cell Lymphoma.
    Kakizaki A; Fujimura T; Kambayashi Y; Furudate S; Kawano M; Ogasawara K; Aiba S
    Acta Derm Venereol; 2015 May; 95(5):600-2. PubMed ID: 25403560
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose.
    Siggaard CB; Kazankov K; Rødgaard-Hansen S; Møller HJ; Donnelly MC; Simpson KJ; Grønbaek H
    Scand J Gastroenterol; 2019 May; 54(5):623-632. PubMed ID: 31067143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.